Published in Nature on June 21, 1990
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44
Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell (2007) 4.39
The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol (1999) 3.70
New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev (1998) 3.43
HD-Zip proteins: members of an Arabidopsis homeodomain protein superfamily. Proc Natl Acad Sci U S A (1992) 2.94
Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One (2008) 2.90
Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol (1991) 2.88
Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev (2002) 2.69
Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol (2002) 2.68
Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell (2008) 2.64
Oct4 is required for primordial germ cell survival. EMBO Rep (2004) 2.56
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res (2002) 2.49
Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS One (2006) 2.46
Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell (2008) 2.21
Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J (1990) 2.19
Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev (2003) 2.10
Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol (1998) 2.03
Genesis of embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (2003) 1.97
Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci U S A (1993) 1.79
Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res (2002) 1.77
Segments of the POU domain influence one another's DNA-binding specificity. Mol Cell Biol (1992) 1.77
A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol Cell Biol (1995) 1.74
Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. Dev Cell (2013) 1.74
The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J (1991) 1.70
Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers. Philos Trans R Soc Lond B Biol Sci (2013) 1.70
The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev (2006) 1.66
UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J (1998) 1.65
Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res (1991) 1.65
Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res (1992) 1.65
5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation. Proc Natl Acad Sci U S A (2004) 1.64
POU proteins bend DNA via the POU-specific domain. EMBO J (1991) 1.62
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol (1994) 1.61
Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci U S A (1992) 1.59
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. Mol Cell Biol (1992) 1.57
Maintaining embryonic stem cell pluripotency with Wnt signaling. Development (2011) 1.57
A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance. Curr Biol (2013) 1.54
Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol (2006) 1.51
Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis. BMC Dev Biol (2007) 1.49
Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res (1991) 1.46
A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol (2013) 1.45
Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol Cell Biol (1994) 1.45
Promiscuous partnerships in Ewing's sarcoma. Cancer Genet (2011) 1.41
Oct4 kinetics predict cell lineage patterning in the early mammalian embryo. Nat Cell Biol (2011) 1.40
Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol (1994) 1.37
Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture. BMC Genomics (2007) 1.34
Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res (1994) 1.32
Piecing together the mosaic of early mammalian development through microRNAs. J Biol Chem (2008) 1.32
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol (1997) 1.25
Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res (2008) 1.25
Sequential expression of multiple POU proteins during amphibian early development. Mol Cell Biol (1992) 1.23
Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region. Mol Cell Biol (1993) 1.22
Mapping the transactivation domain of the Oct-6 POU transcription factor. Nucleic Acids Res (1992) 1.21
Genetics of germ cell development. Nat Rev Genet (2012) 1.20
Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. PLoS One (2011) 1.19
Phosphorylation regulates human OCT4. Proc Natl Acad Sci U S A (2012) 1.19
An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells. Mol Cell Biol (1993) 1.17
The transcriptional regulation of pluripotency. Cell Res (2012) 1.15
The gene encoding the transcription factor SCIP has features of an expressed retroposon. Mol Cell Biol (1991) 1.13
Establishment of trophectoderm and inner cell mass lineages in the mouse embryo. Mol Reprod Dev (2009) 1.12
Oct-4 controls cell-cycle progression of embryonic stem cells. Biochem J (2010) 1.12
Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res Ther (2010) 1.12
Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci U S A (2003) 1.11
Activating transcription factor 1 and CREB are important for cell survival during early mouse development. Mol Cell Biol (2002) 1.11
Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J (1996) 1.10
Isolation, characterization and propagation of mitotically active germ cells from adult mouse and human ovaries. Nat Protoc (2013) 1.09
Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol Cell Biol (1994) 1.09
Early loss of Xist RNA expression and inactive X chromosome associated chromatin modification in developing primordial germ cells. PLoS One (2007) 1.08
Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. Mol Cell Biol (1996) 1.07
Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol Cell Biol (1991) 1.07
Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4. Mol Cell Biol (2001) 1.06
Sperm 1: a POU-domain gene transiently expressed immediately before meiosis I in the male germ cell. Proc Natl Acad Sci U S A (1993) 1.06
Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3. Nucleic Acids Res (1991) 1.06
Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther (2011) 1.05
Dual fluorescent protein reporters for studying cell behaviors in vivo. Genesis (2009) 1.05
Novel gene expression patterns along the proximo-distal axis of the mouse embryo before gastrulation. BMC Dev Biol (2007) 1.05
Hybrid cell extinction and re-expression of Oct-3 function correlates with differentiation potential. EMBO J (1993) 1.04
A fast and sensitive alternative for β-galactosidase detection in mouse embryos. Development (2012) 1.04
Xenopus laevis POU91 protein, an Oct3/4 homologue, regulates competence transitions from mesoderm to neural cell fates. EMBO J (2006) 1.04
Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenet Genome Res (2006) 1.01
Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Mol Cell Biol (1993) 1.00
Endogenous production of fibronectin is required for self-renewal of cultured mouse embryonic stem cells. Exp Cell Res (2012) 0.99
Unraveling the transcriptional network controlling ES cell pluripotency. Genome Biol (2006) 0.98
Two-step oligoclonal development of male germ cells. Proc Natl Acad Sci U S A (2008) 0.98
Cloning, chromosomal localization and expression pattern of the POU domain gene Oct-11. Nucleic Acids Res (1993) 0.97
Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int (2013) 0.97
Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model. J Transl Med (2006) 0.97
Oocyte-specific factors bind a conserved upstream sequence required for mouse zona pellucida promoter activity. Mol Cell Biol (1991) 0.97
The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J (2003) 0.97
Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Mol Cell Biol (1993) 0.96
Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation. Proc Natl Acad Sci U S A (2007) 0.96
Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Res (1996) 0.96
Pluripotency and Epigenetic Factors in Mouse Embryonic Stem Cell Fate Regulation. Mol Cell Biol (2015) 0.95
Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm (2012) 0.95
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
An intronic enhancer containing an N-box motif is required for synapse- and tissue-specific expression of the acetylcholinesterase gene in skeletal muscle fibers. Proc Natl Acad Sci U S A (1999) 0.94
Role of Oct4 in the early embryo development. Cell Regen (Lond) (2014) 0.94
Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Mol Cell Biol (1992) 0.93
Identifying genes preferentially expressed in undifferentiated embryonic stem cells. BMC Cell Biol (2007) 0.93
Transcriptional control of spermatogonial maintenance and differentiation. Semin Cell Dev Biol (2014) 0.93
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Biochemical method for mapping mutational alterations in DNA with S1 nuclease: the location of deletions and temperature-sensitive mutations in simian virus 40. Proc Natl Acad Sci U S A (1975) 7.57
Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev (1988) 7.52
Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol (1981) 6.75
Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med (2001) 6.66
Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (1997) 6.58
Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell (1985) 5.88
McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloning. Nucleic Acids Res (1988) 5.76
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity (2000) 5.36
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A (1993) 4.56
Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell (1996) 4.55
A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol (2000) 4.27
Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation (1982) 4.11
Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09
Activation of mouse genes in transformed cells. Cell (1983) 3.85
Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. Proc Natl Acad Sci U S A (1982) 3.73
Displacement of sequence-specific transcription factors from mitotic chromatin. Cell (1995) 3.71
Signatures of the immune response. Immunity (2001) 3.66
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53
Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev (1991) 3.46
Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol (1980) 3.39
Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature (1982) 3.34
H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J (1992) 3.21
The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev (1993) 3.15
Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol (1992) 3.10
The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58
Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A (1985) 2.56
Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J Immunol (1983) 2.45
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Isolation and characterization of an alphoid centromeric repeat family from the human Y chromosome. J Mol Biol (1985) 2.39
ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity (2000) 2.34
A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain. Cell (1988) 2.32
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood (2000) 2.30
Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol (2000) 2.28
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med (1983) 2.27
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24
Multiple spatially specific enhancers are required to reconstruct the pattern of Hox-2.6 gene expression. Genes Dev (1991) 2.20
The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17
Gene duplication in experimental enzyme evolution. Nature (1974) 2.16
Activation of a Qa/Tla class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature (1984) 2.13
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol (1993) 2.06
H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc Natl Acad Sci U S A (1989) 2.05
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol (1993) 2.02
Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci U S A (2000) 1.99
Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev (1997) 1.97
An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell (1987) 1.96
BCL-6 expression during B-cell activation. Blood (1996) 1.95
Transcripts regulated during normal embryonic development and oncogenic transformation share a repetitive element. Cell (1983) 1.94
Transcriptional repression by the proto-oncogene BCL-6. Oncogene (1996) 1.94
Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.90
A role for the TATA-box-binding protein component of the transcription factor IID complex as a general RNA polymerase III transcription factor. Proc Natl Acad Sci U S A (1992) 1.85
Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem (2001) 1.82
An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol (2000) 1.82
A fragment of the SV40 large T-antigen gene transforms. Nature (1982) 1.82
Regulation of RNA polymerase III transcription in response to F9 embryonal carcinoma stem cell differentiation. Cell (1989) 1.81
Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence. Mol Cell Biol (1987) 1.78
The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding. J Immunol (1984) 1.77
Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J Biochem (1996) 1.77
The medaka rs-3 locus required for scale development encodes ectodysplasin-A receptor. Curr Biol (2001) 1.75
Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc Natl Acad Sci U S A (1988) 1.73
Cloning and characterization of the integrated viral DNA from three lines of SV40-transformed mouse cells. Cell (1981) 1.72
Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem (1997) 1.70
Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. Proc Natl Acad Sci U S A (1983) 1.67
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus. J Virol (1982) 1.64
Genetic lesions involved in temperature sensitivity of the src gene products of four Rous sarcoma virus mutants. J Virol (1986) 1.64
Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res (2001) 1.64
Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med (1997) 1.64
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene. Genes Dev (1993) 1.63
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol (1998) 1.62
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol (2000) 1.61
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J Biol Chem (1992) 1.59
Binding of multiple nuclear factors to the 5' upstream regulatory element of the murine major histocompatibility class I gene. Mol Cell Biol (1987) 1.59
Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci (1985) 1.58
T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci U S A (1998) 1.58
WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci U S A (1995) 1.56
A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development (2001) 1.54
The see-through medaka: a fish model that is transparent throughout life. Proc Natl Acad Sci U S A (2001) 1.54
Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity (1997) 1.51
Fate of viral DNA in nonpermissive cells infected with simian virus 40. Proc Natl Acad Sci U S A (1981) 1.51
Mox2 is a component of the genetic hierarchy controlling limb muscle development. Nature (1999) 1.50
V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J Immunol (1990) 1.49
Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction. Mol Cell Biol (1989) 1.49
Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains. J Exp Med (1984) 1.48
Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet (1993) 1.48
Does simian virus 40 DNA integrate into cellular DNA during productive infection? J Virol (1978) 1.48
The construction of cosmid libraries of eukaryotic DNA using the Homer series of vectors. Nucleic Acids Res (1982) 1.47
Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol (1998) 1.46